• Tweeter

  • republish

Monsanto's Roundup at a store in Encinitas, California, June 26, 2017. REUTERS / Mike Blake

While the chemicals and pharmaceuticals group faces many court cases, it has just benefited from a favorable decision from the US Environmental Protection Agency.

With our correspondent in New York, Loubna Anaki

It's a small win for Monsanto. Since 2017, California has been demanding that the US agricultural giant put on its Roundup herbicide the indication "probable carcinogen". A measure that has just been rejected by the US Environmental Protection Agency in a decision on Thursday. EPA believes that there is no evidence that glyphosate, the main component of Roundup, causes cancer , and adds that it is " irresponsible to require the laying of inaccurate labels on products ."

The announcement comes as Monsanto and its parent company, Bayer, face more than 18,000 court cases across the country.

Bayer Denies Ready to Pay $ 8 Billion to End Complaints

On Friday, American media claimed that Bayer would be willing to pay $ 8 billion for an amicable settlement, while he has already lost three lawsuits. Information immediately denied by the mediator mandated by the US justice in these trials. " It's pure fiction, " he said.

Whether founded or not, the possibility of an out-of-court solution did a temporary good job for the German pharmaceutical group on the financial markets. Bayer shares gained 11% before stabilizing again.

It must be said that the legal risk on the group has caused Bayer shares to lose more than one third of their value in one year. The equivalent of $ 34 billion.